Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Prostate cancer

Risk factors — you find what you are looking for

Nature Reviews Urology volume 14, pages 202–204 (2017)Cite this article

Subjects

Understanding risk factors for prostate cancer is an important step towards personalized, risk-adapted early detection and prevention. Epidemiological studies, which are commonly used to identify risk factors, are prone to detection bias. This bias could substantially affect the observed relationship between putative risk factors and prostate cancer diagnosis.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: The potential for detection bias owing to prostate biopsy indication in the assessment of prostate cancer risk factors.

References

  1. Delgado-Rodríguez, M. & Llorca, J. Bias. J. Epidemiol. Community Health 58, 635–641 (2004).

    Article  Google Scholar 

  2. Tangen, C. M. et al. Biases in recommendations for and acceptance of prostate biopsy significantly affect assessment of prostate cancer risk factors: results from two large randomized clinical trials. J. Clin. Oncol. http://dx.doi.org/10.1200/JCO.2016.68.1965 (2016).

  3. Carter, H. B. et al. Early detection of prostate cancer: AUA guideline. J. Urol. 190, 419–426 (2013).

    Article  Google Scholar 

  4. Thompson, I. M. et al. The influence of finasteride on the development of prostate cancer. N. Engl. J. Med. 349, 215–224 (2003).

    Article  CAS  Google Scholar 

  5. Siddiqui, M. M. et al. Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA 313, 390–397 (2015).

    Article  CAS  Google Scholar 

  6. Coggon, D., Rose, G. & Barker, D. J. P. Epidemiology for the Uninitiated 4th edn (BMJ Publishing Group Ltd, 2016).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Christopher J. D. Wallis is at the Division of Urology, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada,

    Christopher J. D. Wallis

  2. and at the Institute for Health Policy, Management & Evaluation, University of Toronto, 155 College Street, Toronto, Ontario, M5T 3M6, Canada.,

    Christopher J. D. Wallis

  3. Raj Satkunasivam is at the Division of Urology, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, Ontario, M4N 3M5, Canada.,

    Raj Satkunasivam

Authors
  1. Christopher J. D. Wallis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Raj Satkunasivam
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christopher J. D. Wallis.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wallis, C., Satkunasivam, R. Risk factors — you find what you are looking for. Nat Rev Urol 14, 202–204 (2017). https://doi.org/10.1038/nrurol.2016.267

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2016.267

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer